| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |